The number of CD45+IL-10+ cells in the peripheral blood mononuclear cells (PBMCs) of CRC patients who did not receive chemotherapy was significantly higher than that in patients who received chemotherapy (Figures 7(i,j)). The gene discussed is IL10; the disease is colorectal carcinoma.